Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Sarcoma, Synovial × Ado-Trastuzumab Emtansine × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Neoplasm Metastasis 4 Neoplasms 3 Salivary Gland Neoplasms 2 HER2-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Unrespectable Locally Advanced and or Metastatic HER2 Positive Breast Cancer Participants 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Patient Preference 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Hemangiosarcoma 1 Heart Failure 1 HER2-positive Metastatic Breast Cancer 1 HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy 1 HER2-Positive Primary Breast Cancer 1 Genomic Instability 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

Cyclophosphamide 6 fludarabine 4 tazemetostat 2 pembrolizumab 2 Doxorubicin 2 tremelimumab 1 sotigalimab 1 pazopanib 1 fludarabine phosphate 1 durvalumab 1 anlotinib 1 aldesleukin 1 Zoledronic Acid 1 X-Rays 1 Trabectedin 1 Tablets 1 Specimen Handling 1 Rosuvastatin Calcium 1 Radiotherapy 1 Radiation 1 Quality of Life 1 Phantoms, Imaging 1 Midazolam 1 Magnetic Resonance Spectroscopy 1 Leukapheresis 1 Interleukin-2 1 Immunotherapy, Adoptive 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Digoxin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡